Logo
  • Home
  • About
  • D-VITylation® Technology
  • Pipeline
  • Partnering
  • News
  • Contact

Extend Biosciences has been awarded a third patent

Posted on April 11, 2017

Extend Biosciences’ third patent has been awarded by the USPTO. The patent, titled “Insulin Vitamin D Conjugates” issued April 11, 2017 (US 9,616,109). 

Latest News

  • Extend Biosciences is Selected to Present in the NIH Innovation Zone at BIO2024
  • A Manuscript on the Preclinical Development of EXT608 Has Been Published
  • Extend Biosciences Becomes a Founding Member of the AmCham Abu Dhabi Biotech Committee
  • Abstract Describing the Phase 1 Clinical Trial Data for EXT608 is Selected for the plenary session at ASBMR
  • FDA’s Office of Orphan Products Development Awards Extend Biosciences Grant Funding to Begin Phase 2a Trials for EXT608

Connect With Us

    footer-logo

    © 2026 Extend Biosciences, Inc. All rights reserved. Website developed by Siphon Marketing